Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT. Newton Bishop JA, et al. Among authors: bishop dt. Br J Cancer. 1999 Apr;80(1-2):295-300. doi: 10.1038/sj.bjc.6690354. Br J Cancer. 1999. PMID: 10390011 Free PMC article.
The genetics of melanoma.
Bishop JN, Harland M, Bishop DT. Bishop JN, et al. Among authors: bishop dt. Br J Hosp Med (Lond). 2006 Jun;67(6):299-304. doi: 10.12968/hmed.2006.67.6.21288. Br J Hosp Med (Lond). 2006. PMID: 16821732 Review.
Germline mutations of the CDKN2 gene in UK melanoma families.
Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf AM, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN. Harland M, et al. Among authors: bishop dt, bishop jn. Hum Mol Genet. 1997 Nov;6(12):2061-7. doi: 10.1093/hmg/6.12.2061. Hum Mol Genet. 1997. PMID: 9328469
Mutation screening of the CDKN2A promoter in melanoma families.
Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J. Harland M, et al. Among authors: bishop dt. Genes Chromosomes Cancer. 2000 May;28(1):45-57. Genes Chromosomes Cancer. 2000. PMID: 10738302
Genetic heterogeneity in familial malignant melanoma.
MacGeoch C, Bishop JA, Bataille V, Bishop DT, Frischauf AM, Meloni R, Cuzick J, Pinney E, Spurr NK. MacGeoch C, et al. Among authors: bishop dt, bishop ja. Hum Mol Genet. 1994 Dec;3(12):2195-200. doi: 10.1093/hmg/3.12.2195. Hum Mol Genet. 1994. PMID: 7881419
The genetics of melanoma: the UK experience.
Newton Bishop JA, Harland M, Bishop DT. Newton Bishop JA, et al. Among authors: bishop dt. Clin Exp Dermatol. 1998 Jul;23(4):158-61. doi: 10.1046/j.1365-2230.1998.00344.x. Clin Exp Dermatol. 1998. PMID: 9894359 Review.
Melanoma sentinel node biopsy and prediction models for relapse and overall survival.
Mitra A, Conway C, Walker C, Cook M, Powell B, Lobo S, Chan M, Kissin M, Layer G, Smallwood J, Ottensmeier C, Stanley P, Peach H, Chong H, Elliott F, Iles MM, Nsengimana J, Barrett JH, Bishop DT, Newton-Bishop JA. Mitra A, et al. Among authors: bishop dt. Br J Cancer. 2010 Oct 12;103(8):1229-36. doi: 10.1038/sj.bjc.6605849. Epub 2010 Sep 21. Br J Cancer. 2010. PMID: 20859289 Free PMC article.
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium. Demenais F, et al. Among authors: bishop dt. J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28. J Natl Cancer Inst. 2010. PMID: 20876876 Free PMC article.
437 results